BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/11/2023 11:04:22 AM | Browse: 235 | Download: 520
 |
Received |
|
2023-01-29 12:22 |
|
Peer-Review Started |
|
2023-01-29 12:25 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2023-03-01 00:40 |
|
Revised |
|
2023-03-21 16:20 |
|
Second Decision |
|
2023-05-19 03:07 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2023-05-23 00:22 |
|
Articles in Press |
|
2023-05-23 00:22 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2023-06-15 16:49 |
|
Typeset the Manuscript |
|
2023-08-07 06:03 |
|
Publish the Manuscript Online |
|
2023-08-11 11:04 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Biochemistry & Molecular Biology |
| Manuscript Type |
Review |
| Article Title |
Advanced glycation end products: Key mediator and therapeutic target of cardiovascular complications in diabetes
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Savita Bansal, Archana Burman and Asok Kumar Tripathi |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Savita Bansal, PhD, Assistant Professor, Department of Biochemistry, Institute of Home Sciences, University of Delhi, Hauz Khas, New Delhi 110016, India. savita.bansal@ihe.du.ac.in |
| Key Words |
Type 2 diabetes mellitus; Cardiovascular complications; Hyperglycemia; Advanced glycation end products; Reactive oxygen species; Oxidative stress; Endothelial cells; Receptor of advanced glycation end products; Anti-advanced glycation end products strategies |
| Core Tip |
Cardiovascular diseases (CVD) in type 2 diabetes mellitus impose a clinical and an economic burden on the healthcare system. Early diagnosis of diabetes may prevent its progression to complications and decrease its associated co-morbidities. The present manuscript reports the clinical relevance of estimating advanced glycation end products (AGEs) in diabetes. The deleterious effects of AGEs include many important biochemical reactions central to the development and progression of cardiovascular complications in diabetes. Therefore, AGEs are one of the important targets for future diagnosis and prevention of diabetes. The epidemiology of CVD in diabetes, AGEs as a crucial mediator of diabetic-CVD, and an overview of different strategies for countering the accumulation of AGEs is discussed along with new therapeutic interventions to ameliorate their effects. |
| Publish Date |
2023-08-11 11:04 |
| Citation |
Bansal S, Burman A, Tripathi AK. Advanced glycation end products: Key mediator and therapeutic target of cardiovascular complications in diabetes. World J Diabetes 2023; 14(8): 1146-1162 |
| URL |
https://www.wjgnet.com/1948-9358/full/v14/i8/1146.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v14.i8.1146 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
